[go: up one dir, main page]

NO20002450D0 - Compilation of active ingredients, in particular tetrahydropyridines and acetylcholinesterase inhibitors, for the treatment of Alzheimer's senile dementia - Google Patents

Compilation of active ingredients, in particular tetrahydropyridines and acetylcholinesterase inhibitors, for the treatment of Alzheimer's senile dementia

Info

Publication number
NO20002450D0
NO20002450D0 NO20002450A NO20002450A NO20002450D0 NO 20002450 D0 NO20002450 D0 NO 20002450D0 NO 20002450 A NO20002450 A NO 20002450A NO 20002450 A NO20002450 A NO 20002450A NO 20002450 D0 NO20002450 D0 NO 20002450D0
Authority
NO
Norway
Prior art keywords
tetrahydropyridines
compilation
alzheimer
treatment
active ingredients
Prior art date
Application number
NO20002450A
Other languages
Norwegian (no)
Other versions
NO20002450L (en
Inventor
Jean-Pierre Maffrand
Philippe Soubrie
Jean-Paul Terranova
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9714324A external-priority patent/FR2771006B1/en
Priority claimed from FR9714322A external-priority patent/FR2771007B1/en
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO20002450D0 publication Critical patent/NO20002450D0/en
Publication of NO20002450L publication Critical patent/NO20002450L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20002450A 1997-11-14 2000-05-11 Composition of active ingredients, in particular tetrahydropyridines and acetylcholinesterase inhibitors, for the treatment of senile dementia of Alzheimer's type NO20002450L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9714324A FR2771006B1 (en) 1997-11-14 1997-11-14 COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE
FR9714322A FR2771007B1 (en) 1997-11-14 1997-11-14 COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE
PCT/FR1998/002384 WO1999025363A1 (en) 1997-11-14 1998-11-09 Combination of active principles, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia

Publications (2)

Publication Number Publication Date
NO20002450D0 true NO20002450D0 (en) 2000-05-11
NO20002450L NO20002450L (en) 2000-07-14

Family

ID=26233932

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002450A NO20002450L (en) 1997-11-14 2000-05-11 Composition of active ingredients, in particular tetrahydropyridines and acetylcholinesterase inhibitors, for the treatment of senile dementia of Alzheimer's type

Country Status (27)

Country Link
EP (1) EP1030671A1 (en)
JP (1) JP2001523642A (en)
KR (1) KR100599350B1 (en)
CN (1) CN1243540C (en)
AU (1) AU743228B2 (en)
BG (1) BG64819B1 (en)
BR (1) BR9814035A (en)
CA (1) CA2309966A1 (en)
CO (1) CO4980891A1 (en)
DZ (1) DZ2649A1 (en)
EA (1) EA003255B1 (en)
EE (1) EE04235B1 (en)
HU (1) HUP0100098A3 (en)
ID (1) ID24933A (en)
IL (2) IL136122A0 (en)
IS (1) IS5482A (en)
MY (1) MY120461A (en)
NO (1) NO20002450L (en)
NZ (1) NZ504420A (en)
OA (1) OA11464A (en)
PL (1) PL194597B1 (en)
SA (1) SA98190747B1 (en)
SK (1) SK286040B6 (en)
TR (1) TR200001262T2 (en)
TW (1) TW585766B (en)
UY (1) UY25247A1 (en)
WO (1) WO1999025363A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4675103B2 (en) * 2002-06-14 2011-04-20 富山化学工業株式会社 Pharmaceutical composition for improving brain function and method for improving brain function
CA2494585A1 (en) * 2002-08-07 2004-02-19 Novartis Ag Methods for the treatment of dementia based on apo e genotype
CN1520818A (en) * 2003-02-09 2004-08-18 山东绿叶天然药物研究开发有限公司 Cholinesterase inhibitor pharmaceutical composition for senile dementia
CA2592605C (en) 2004-12-27 2010-12-07 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
CN106163516B (en) 2014-01-31 2019-05-28 考格尼申治疗股份有限公司 Isoindoline compositions and methods of treating neurodegenerative diseases
CN110869011B (en) 2017-05-15 2024-01-05 考格尼申治疗股份有限公司 Compositions for treating neurodegenerative diseases
KR102224918B1 (en) 2018-03-20 2021-03-09 (주)인벤티지랩 Pharmaceutiical composition comprising memantine and donepezil for preventing or treating cognitive impairment-related disease and preparation method thereof
WO2019182319A1 (en) * 2018-03-20 2019-09-26 (주)인벤티지랩 Method for preparing pharmaceutical composition for preventing or treating cognitive disorder-associated diseases, and pharmaceutical composition for preventing or treating cognitive disorder-associated diseases, prepared by preparation method
CN109265391B (en) * 2018-11-13 2021-11-19 枣庄学院 Biphenyl polysubstituted 1,2,5, 6-tetrahydropyridine compound and synthetic method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662355B1 (en) * 1990-05-22 1994-11-10 Sanofi Sa USE OF 1- [2- (2-NAPHTYL) ETHYL] -4- (3-TRIFLUOROMETHYLPHENYL) -1,2,3,6-TETRAHYDROPYRIDINE FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF BRAIN AND NEURAL DISORDERS.
US5453428A (en) * 1991-02-14 1995-09-26 The Mount Sinai School Of Medicine Of The City Of New York Method and composition for the treatment of apathy-amotivation syndrome
JPH11511732A (en) * 1995-03-06 1999-10-12 インターニューロン ファーマシューティカルズ，インコーポレーテッド Reduction of infarct volume using citicoline
FR2736053B1 (en) * 1995-06-28 1997-09-19 Sanofi Sa NEWS 1-PHENYLALKYL-1,2,3,6-TETRAHYDROPYRIDINES

Also Published As

Publication number Publication date
DZ2649A1 (en) 2004-12-28
KR20010032099A (en) 2001-04-16
AU743228B2 (en) 2002-01-24
SA98190747B1 (en) 2006-11-04
IS5482A (en) 2000-05-09
CA2309966A1 (en) 1999-05-27
TW585766B (en) 2004-05-01
ID24933A (en) 2000-08-31
BG64819B1 (en) 2006-05-31
IL136122A (en) 2006-07-05
SK286040B6 (en) 2008-01-07
HUP0100098A2 (en) 2001-07-30
EA200000412A1 (en) 2000-12-25
TR200001262T2 (en) 2001-01-22
BG104428A (en) 2001-08-31
SK7112000A3 (en) 2000-10-09
HUP0100098A3 (en) 2001-12-28
EA003255B1 (en) 2003-02-27
KR100599350B1 (en) 2006-07-12
PL340500A1 (en) 2001-02-12
NO20002450L (en) 2000-07-14
AU1160999A (en) 1999-06-07
CN1285742A (en) 2001-02-28
OA11464A (en) 2003-11-18
IL136122A0 (en) 2001-05-20
EP1030671A1 (en) 2000-08-30
NZ504420A (en) 2003-08-29
PL194597B1 (en) 2007-06-29
MY120461A (en) 2005-10-31
EE04235B1 (en) 2004-02-16
EE200000290A (en) 2001-06-15
WO1999025363A1 (en) 1999-05-27
CO4980891A1 (en) 2000-11-27
JP2001523642A (en) 2001-11-27
CN1243540C (en) 2006-03-01
UY25247A1 (en) 2001-05-31
BR9814035A (en) 2000-09-26

Similar Documents

Publication Publication Date Title
NO20004098D0 (en) Methods and preparations for the treatment of macrophage-mediated disorders
NO972972L (en) Compositions for the treatment of dermatological disorders and methods for their use
DE69612185D1 (en) BLEACHING METHOD AND BLENDER COMPOSITION
DE69312624D1 (en) DEVICE FOR DISTINATING TACHYCARDIA AND FIBRILLATIONS AND FOR THE TREATMENT THEREOF
DE60022867D1 (en) 1-Arenesulfonyl-2-aryl-pyrrolidine and piperidine Derivatives for the treatment of CNS disorders
ZA964762B (en) Peptidyl heterocycles useful in the treatment of thrombin related disorders.
NO20001412D0 (en) Compositions and Methods in the Treatment of Respiratory Disorders
NO20012963D0 (en) Process for the preparation of 3-alkanoylindoles and 3-alkylindoles
ZA964761B (en) Peptidyl heterocycles useful in the treatment of thrombin related disorders.
NO20002450D0 (en) Compilation of active ingredients, in particular tetrahydropyridines and acetylcholinesterase inhibitors, for the treatment of Alzheimer's senile dementia
HUP0103832A3 (en) Triazolopyridines for the treatment of thrombosis disorders, pharmaceutical compositions containing the same and process for preparation thereof
DE69822676D1 (en) Rolling plant and rolling process
NO995469D0 (en) Method for the treatment of mental disorders in mammals and a composition thereof
IL131085A0 (en) The use of levobupivacaine or ropivacaine in treating migraine
PT1152762E (en) USE OF DEOXYGEGANIN IN THE TREATMENT OF ALZHEIMER'S DEMENTIA
EP1181308A4 (en) Methods for the treatment of neuronal atrophy-associated dementia
DE69802498D1 (en) COMBINATION PRODUCT CONTAINING IDEBENON FOR ALZHEIMER TREATMENT
AU5963396A (en) Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
ATE224711T1 (en) FORMULATION FOR THE TREATMENT AND/OR PREVENTION OF DEMENTIA
NO971419L (en) Process for Preparation of 1,3-Alkenediols and 3-Hydroxyaldehydes
NO20022990L (en) Method and composition for the treatment of pain
DE69908572D1 (en) METAL TREATMENT
DE69726054D1 (en) CELLS FOR THE TREATMENT OF DEMENTIA
ZA989955B (en) Combination of active ingredients for the treatment of senile dementia of the alzheimer type
HK1028354A (en) Combination of active principles, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia